Among the immune checkpoints, the PD-1/PD-L1 pathway could represent an attractive target as it has been reported not only to inhibit human T cell responses, thus promoting immune evasion of tumor cells [28], but also to induce tumor cell proliferation [29]. This evidence concerns the gene CD274 and neoplasm.